PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A. (Q39025431)
Jump to navigation
Jump to search
scientific article published on 10 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A. |
scientific article published on 10 February 2014 |
Statements
1 reference
PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A. (English)
1 reference
Bo Cui
1 reference
Qi Yang
1 reference
Haixia Guan
1 reference
Bingyin Shi
1 reference
Peng Hou
1 reference
Meiju Ji
1 reference
10 February 2014
1 reference
1 reference
99
1 reference
6
1 reference
E962-70
1 reference
Identifiers
1 reference
1 reference